Sibling Group Holdings, Inc. SIBE Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 13, 2013 at 7:26 PM

Sibling Group Holdings, Inc. SIBE Company Overview

Stock Message Board http://investorshangout.com/search?q=SIBE&...mp;yt1=Go!

Sibling Group Holdings, Inc. SIBE Current Price and Quotes
Last Price 0.055
Previous Close 0.0625 Open 0.062
Daily Range 0.062 - 0.055 52wk Range 1.99 - 0.035
Volume 71,000 Dividend N/A
Average Vol (3m) 315,936 Yield N/A
Sibling Group Holdings, Inc. SIBE

Company Verified Profile
Company Information

1355 Peachtree Street
Suite 1150
Atlanta, GA 30309

Website: http://www.siblinggroup.com
Phone: 404-551-5274
Email: info@siblinggroup.com

Sibling Group Holdings, Inc. SIBE
Through the use of multiple teaching and learning modalities, Sibling Group Holdings, Inc. (SIBE) intends to acquire, on a global basis, advanced technology and education management operations in order to enhance and accelerate the delivery of 21st century learning. The mission will be accomplished by accessing funds from the public capital markets and melding them into a unified strategy that will help accelerate the improvement of K-12 education across the globe. The results: better educated ...

Sibling Group Holdings, Inc. SIBE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Mar 31, 2013 10-Q
CIK 0001099728
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 8200 - Services-Educational Services
Business Status Development Stage Company a/o Jun 30, 2013
Incorporated In: TX, USA
Year of Inc. 2009
Employees 5 a/o Jun 30, 2013
Company Officers/Contacts

Neal Sessions CEO, CFO
Company Directors

Neal Sessions Chairman
Michael Hanlon
Andrew Honeycutt
Amy Savage-Austin
Pierce Sullivan
Company Notes

Formerly=Sibling Entertainment Group Holdings, Inc. until 8-2012
Formerly=Sona Development Corp. until 6-07
Formerly=Net Master Consultants, Inc. until 12-02
Note=12-31-04 company is in the development stage, seeking a potential internet sector merger or acquisition candidate
Service Providers

Auditor/Accountant
Liggett, Vogt & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States

Legal Counsel
Krevolin & Horst, LLC
One Atlantic Center
Atlanta, GA, 30309
United States

Investor Relations Firm
Not Available

Sibling Group Holdings, Inc. SIBE
SIBE Security Details

Share Structure

Market Value1 $1,244,126 a/o Sep 12, 2013
Shares Outstanding 19,906,023 a/o Sep 11, 2013
Float Not Available
Authorized Shares 500,000,000 a/o Jul 05, 2013
Par Value 0.0001
Shareholders

Shareholders of Record 600 a/o May 08, 2013
Security Notes

Capital Change=shs increased by 2 for 1 split. Ex-date=01/31/2000. Rec date=01/28/2000. Pay date=01/31/2000.
Capital Change=shs decreased by 1 for 10 split Pay date=12/17/2002.
Capital Change=shs decreased by 1 for 100 split. Ex-date=08/21/2012.
Short Selling Data

Short Interest 1,000 (-70.65%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Interwest Transfer Co., Inc.

Sibling Group Holdings, Inc. SIBE Recent News

Aug 26, 2013 Sibling Group Delivers Special Education Offerings for School Faculty
Aug 21, 2013 Sibling Group's ClassChatter.com Passes 136,000 Users
Jul 23, 2013 Sibling Group Announces ClassChatter.com, Award Winning App, in Expanded Version
Jul 19, 2013 Sibling Group Addresses Social and Emotional Learning Strategies
Jul 18, 2013 Sibling Group Updates on Acquisition and Development Plans
Jul 17, 2013 Sibling Group Announces Course Library for the Teaching Profession
Jul 11, 2013 Sibling Group Enters "Special Education" Market

Sibling Group Holdings, Inc. SIBE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 3,669 2,245 334 390
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,669) (2,245) (334) (390)
Income From Continuing Operations

Add'l Income/Expense Items - (108) - 383
Earnings Before Interest and Tax (3,669) (2,245) (334) (7)
Interest Expense 17 10 1 408
Earnings Before Tax (3,687) (2,255) (334) (414)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,687) (2,363) (334) (414)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,687) (2,363) (334) (414)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,687) (2,363) (334) (414)

SIBE Sibling Group Holdings, Inc. Research DD Guide

SIBE Sibling Group Holdings, Inc. Stock Message Board http://investorshangout.com/search?q=SIBE&...mp;yt0=Go!
SIBE Sibling Group Holdings, Inc. Stock Quote http://www.otcmarkets.com/stock/SIBE/quote
SIBE Sibling Group Holdings, Inc. Stock Chart http://www.otcmarkets.com/stock/SIBE/chart
SIBE Sibling Group Holdings, Inc. Company Info http://www.otcmarkets.com/stock/SIBE/company-info
SIBE Sibling Group Holdings, Inc. Recent News http://www.otcmarkets.com/stock/SIBE/news
SIBE Sibling Group Holdings, Inc. Financials http://www.otcmarkets.com/stock/SIBE/financials
SIBE Sibling Group Holdings, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/SIBE/filings
SIBE Sibling Group Holdings, Inc. Short Sales http://www.otcmarkets.com/stock/SIBE/short-sales
SIBE Sibling Group Holdings, Inc. Insider Disclosure http://www.otcmarkets.com/stock/SIBE/insider-transactions
SIBE Sibling Group Holdings, Inc. Research Reports http://www.otcmarkets.com/stock/SIBE/research
SIBE Sibling Group Holdings, Inc. Summary http://finance.yahoo.com/q?s=SIBE
SIBE Sibling Group Holdings, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=SIBE+Historical+Prices
SIBE Sibling Group Holdings, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=SIBE
SIBE Sibling Group Holdings, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=SIBE+Basic+Chart
SIBE Sibling Group Holdings, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SIBE+Basic+Tech.+Analysis
SIBE Sibling Group Holdings, Inc. Headlines http://finance.yahoo.com/q/h?s=SIBE+Headlines
SIBE Sibling Group Holdings, Inc. Press Releases http://finance.yahoo.com/q/p?s=SIBE+Press+Releases
SIBE Sibling Group Holdings, Inc. Company Profile http://finance.yahoo.com/q/pr?s=SIBE+Profile
SIBE Sibling Group Holdings, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=SIBE+Key+Statistics
SIBE Sibling Group Holdings, Inc. Industry http://finance.yahoo.com/q/in?s=SIBE+Industry
SIBE Sibling Group Holdings, Inc. Major Holders http://finance.yahoo.com/q/mh?s=SIBE+Major+Holders
SIBE Sibling Group Holdings, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=SIBE+Insider+Transactions
SIBE Sibling Group Holdings, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=SIBE+Insider+Roster
SIBE Sibling Group Holdings, Inc. Income Statement http://finance.yahoo.com/q/is?s=SIBE
SIBE Sibling Group Holdings, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=SIBE
SIBE Sibling Group Holdings, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=SIBE+Cash+Flow&annual
SIBE Sibling Group Holdings, Inc. Nasdaq http://www.nasdaq.com/symbol/SIBE
SIBE Sibling Group Holdings, Inc. Market Watch http://www.marketwatch.com/investing/stock/SIBE
SIBE Sibling Group Holdings, Inc. Bloomberg http://www.bloomberg.com/quote/SIBE:US
SIBE Sibling Group Holdings, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=SIBE
SIBE Sibling Group Holdings, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=SIBE
SIBE Sibling Group Holdings, Inc. Barchart http://www.barchart.com/quotes/stocks/SIBE
SIBE Sibling Group Holdings, Inc. OTC Short Report http://otcshortreport.com/index.php?index=SIBE
SIBE Sibling Group Holdings, Inc. Investopedia http://www.investopedia.com/markets/stocks/SIBE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photocure Navigates AssureMDx's Medicare Journey

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Segway Powersports Ventures into Baja 1000: Ambitions Run High

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

UAE Pioneers eATA Carnet System Beyond Europe

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Valmet Expands Board Maker Deal in Asia With New Line

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

AI Agents Redefine Finance: Deutsche & Ant Tech

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...